Protalix BioTherapeutics (PLX) EBT Margin (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Protalix BioTherapeutics | 164.49 Mn | 153.70 Mn | 29.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10,372.00 |
| Dec 31, 2025 | -5,362.00 |
| Sep 30, 2025 | 832.00 |
| Jun 30, 2025 | 4,112.00 |
| Mar 31, 2025 | -10,203.00 |
| Dec 31, 2024 | 4,372.00 |
| Sep 30, 2024 | 3,826.00 |
| Jun 30, 2024 | 10,942.00 |
| Mar 31, 2024 | 8,403.00 |
| Dec 31, 2023 | -19,369.00 |
| Sep 30, 2023 | -7,263.00 |
| Jun 30, 2023 | 8,664.00 |
| Mar 31, 2023 | 663.00 |
| Dec 31, 2022 | -1,210.00 |
| Sep 30, 2022 | 3,579.00 |
| Jun 30, 2022 | -4,673.00 |
| Mar 31, 2022 | 6,315.00 |
| Dec 31, 2021 | -4,173.00 |
| Sep 30, 2021 | 14,126.00 |
| Jun 30, 2021 | -12,512.00 |
| Mar 31, 2021 | -5,341.00 |
| Dec 31, 2020 | 4,385.00 |
| Sep 30, 2020 | -403.00 |
| Jun 30, 2020 | -4,495.00 |
| Mar 31, 2020 | 597.00 |
| Dec 31, 2019 | 2,602.00 |
| Sep 30, 2019 | 3,802.00 |
| Jun 30, 2019 | 816.00 |
| Mar 31, 2019 | 24,369.00 |
| Dec 31, 2018 | 52,231.00 |
| Sep 30, 2018 | -41,183.00 |
| Jun 30, 2018 | -26,368.00 |
| Mar 31, 2018 | 42,133.00 |
| Dec 31, 2017 | -43,115.00 |
| Sep 30, 2017 | 6,576.00 |
| Jun 30, 2017 | 29,565.00 |
| Mar 31, 2017 | -2,348.00 |
| Dec 31, 2016 | -32,816.00 |
| Sep 30, 2016 | 45,048.00 |
| Jun 30, 2016 | 67,899.00 |
| Sep 30, 2015 | 1,452.00 |
| Jun 30, 2015 | -7,943.00 |
| Mar 31, 2014 | -32,089.00 |
| Dec 31, 2013 | 45,779.00 |
| Sep 30, 2013 | 5,735.00 |
| Jun 30, 2013 | -17,998.00 |
| Mar 31, 2013 | 74,297.00 |
| Dec 31, 2012 | -71,819.00 |
| Sep 30, 2012 | -18,614.00 |
| Jun 30, 2012 | 19,392.00 |
| Mar 31, 2012 | 21,794.00 |
| Dec 31, 2011 | 39,945.00 |
| Sep 30, 2011 | 104,071.00 |
| Jun 30, 2011 | -169,314.00 |
| Mar 31, 2011 | 63,034.00 |
| Dec 31, 2010 | -66,293.00 |
| Sep 30, 2010 | 80,012.00 |